NCT01444547 |
|
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin
|
View
|
NCT00953511 |
|
Cologne Esophageal Response Prediction Study CERP-Study
|
View
|
NCT01556191 |
|
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
|
View
|
NCT01240590 |
|
A Phase III Trial of Crolibulin EPC2407 Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer ATC
|
View
|
NCT01989546 |
|
Pilot Trial of BMN 673 an Oral PARP Inhibitor in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
|
View
|
NCT01074398 |
|
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
|
View
|
NCT00174629 |
|
GILT Docetaxel - Non-Small Cell Lung Cancer
|
View
|
NCT02838745 |
|
Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM
|
View
|
NCT04466189 |
|
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
|
View
|
NCT00582634 |
|
Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer
|
View
|
NCT00736814 |
|
First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
|
View
|
NCT00792701 |
|
S0720 Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
|
View
|
NCT02128906 |
|
Radiotherapy With Cisplatin vs Docetaxel-cetuximab in HNSCC ERCC1 Biomarker Enrichment and Interaction Design
|
View
|
NCT01188109 |
|
GemcitabineCisplatin for Resected Pancreas Cancer Establishing the Role of ERCC1 in Treatment Decision
|
View
|
NCT01280643 |
|
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
|
View
|
NCT01781988 |
|
Personalized Therapy in Non-small Cell Lung Cancer
|
View
|
NCT01784549 |
|
Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA N2Disease
|
View
|
NCT01524575 |
|
Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1
|
View
|
NCT01648517 |
|
Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 RRM1 as First-line Chemotherapy
|
View
|
NCT01703390 |
|
Biomarker Directed Treatment in Metastatic Colorectal Cancer
|
View
|
NCT01967875 |
|
A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
|
View
|
NCT03402048 |
|
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial
|
View
|
NCT00006155 |
|
SU5416 and Carboplatin to Treat Ovarian Cancer
|
View
|
NCT05247671 |
|
Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity
|
View
|
NCT05832593 |
|
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 ERCC1 in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy
|
View
|
NCT01071655 |
|
Selecting Treatment in Colorectal CancerCapecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer
|
View
|
NCT01141686 |
|
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
|
View
|
NCT00705549 |
|
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1 RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
|
View
|
NCT01192750 |
|
Biomakers in Tissue Samples From Patients With Recurrent andor Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
|
View
|
NCT00499109 |
|
Phase III of RRM1 ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
|
View
|
NCT00634647 |
|
Satraplatin and Prednisone to Treat Prostate Cancer
|
View
|
NCT00775385 |
|
TAilored Post-Surgical Therapy in Early Stage NSCLC
|
View
|
NCT00797238 |
|
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
|
View
|
NCT00801736 |
|
ERCC1 Targeted Trial
|
View
|